Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

NCT02554396 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Presbyopia

Interventions

DRUG: PRX-100
DRUG: Placebo

Sponsor

LENZ Therapeutics, Inc